1. Home
  2. SCPH vs MTA Comparison

SCPH vs MTA Comparison

Compare SCPH & MTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCPH
  • MTA
  • Stock Information
  • Founded
  • SCPH 2013
  • MTA 1983
  • Country
  • SCPH United States
  • MTA Canada
  • Employees
  • SCPH N/A
  • MTA N/A
  • Industry
  • SCPH Biotechnology: Pharmaceutical Preparations
  • MTA
  • Sector
  • SCPH Health Care
  • MTA
  • Exchange
  • SCPH Nasdaq
  • MTA Nasdaq
  • Market Cap
  • SCPH 274.7M
  • MTA 264.7M
  • IPO Year
  • SCPH 2017
  • MTA N/A
  • Fundamental
  • Price
  • SCPH $3.26
  • MTA $2.60
  • Analyst Decision
  • SCPH Strong Buy
  • MTA
  • Analyst Count
  • SCPH 2
  • MTA 0
  • Target Price
  • SCPH $15.00
  • MTA N/A
  • AVG Volume (30 Days)
  • SCPH 544.0K
  • MTA 452.6K
  • Earning Date
  • SCPH 11-13-2024
  • MTA 11-14-2024
  • Dividend Yield
  • SCPH N/A
  • MTA N/A
  • EPS Growth
  • SCPH N/A
  • MTA N/A
  • EPS
  • SCPH N/A
  • MTA N/A
  • Revenue
  • SCPH $30,278,000.00
  • MTA $5,048,000.00
  • Revenue This Year
  • SCPH $174.12
  • MTA $44.57
  • Revenue Next Year
  • SCPH $133.41
  • MTA $126.18
  • P/E Ratio
  • SCPH N/A
  • MTA N/A
  • Revenue Growth
  • SCPH 303.87
  • MTA 28.55
  • 52 Week Low
  • SCPH $3.08
  • MTA $2.32
  • 52 Week High
  • SCPH $6.71
  • MTA $4.08
  • Technical
  • Relative Strength Index (RSI)
  • SCPH 43.13
  • MTA 30.99
  • Support Level
  • SCPH $3.11
  • MTA $2.62
  • Resistance Level
  • SCPH $3.67
  • MTA $2.85
  • Average True Range (ATR)
  • SCPH 0.21
  • MTA 0.13
  • MACD
  • SCPH 0.01
  • MTA -0.01
  • Stochastic Oscillator
  • SCPH 31.54
  • MTA 3.74

About SCPH scPharmaceuticals Inc.

scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.

About MTA Metalla Royalty & Streaming Ltd.

Metalla Royalty & Streaming Ltd is a precious metals royalty and streaming company, which engages in the acquisition and management of precious metal royalties, streams, and similar production-based interests. It's a pure-play gold and silver streaming and royalty company. It generates revenue from royalties, streams, and other interests.

Share on Social Networks: